The short answer
Becton, Dickinson and Company is HALAL in ZakatInvest's qualitative activity classification, but its current asset-based financial result is FAIL. Debt is 34.00% of total assets, just above the 33% limits used in the examined FTSE Yasaar, MSCI and Malaysia calculations.
This is a reproducible research screen, not a fatwa or investment recommendation. Readers should apply their school's principles and consult a qualified scholar for a binding ruling.
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-13.
17,279 / 50,832
816 / 50,832
3,018 / 50,832
13 / 9,200
- Financial
- Fails
- Overall
- Fails
Debt is 34.00%, just above the examined 33.333% FTSE asset limit. Liquidity is 1.61%, receivables plus cash are 5.94%, and disclosed interest income is 0.14%; debt is decisive.
- Financial
- Fails
- Overall
- Fails
Debt is 34.00%, above the examined MSCI total-assets limit, while liquidity is 1.61% and receivables plus cash are 5.94%. This is a calculation against the named method, not an index-membership claim.
- Financial
- Fails
- Overall
- Fails
Debt is 34.00%, above the examined 33% Malaysia SAC financial limit; liquidity is 1.61%. This is a calculation against SAC ratios, not an official classification of a U.S.-listed security.
- Financial
- Not calculated
- Overall
- Not calculated
A properly licensed and reproducible historical market-cap series is not stored, so these methods are not estimated from a current spot price.
Business-activity disclosure
Becton, Dickinson and Company makes medical devices, diagnostics, medication-management systems, specimen-collection products, laboratory instruments and interventional products. Medical technology and healthcare-equipment manufacturing is generally permissible at the activity level, while product use, research and customer applications remain qualitative review topics.
Limitation: The filing does not allocate a universal prohibited-revenue numerator by product, customer use, ingredient or certification; no exact prohibited-revenue percentage is asserted.
Purification
Becton, Dickinson and Company discloses interest income but does not prescribe a scholar-approved purification percentage. Readers should follow the qualified scholar or methodology they use rather than applying an invented fixed rate.
Inputs, assumptions and primary sources
- Inputs use Becton, Dickinson and Company's March 31, 2026 Form 10-Q; amounts are USD millions and revenue and interest income are for the six months ended March 31, 2026.
- Debt uses $2,573 million of current debt obligations plus $14,706 million of long-term debt; restricted cash and operating liabilities are not added separately.
- Cash uses $813 million of cash and equivalents. Short-term investments of $3 million are treated as interest-bearing securities; restricted cash of $202 million is not treated as cash equivalents.
- Receivables use $2,205 million of net trade receivables. Inventories and other current assets are not added.
- Six-month revenue is $9,200 million and disclosed interest income is $13 million. The screen does not infer a fixed purification rate.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Current quantitative screen
The calculations use Becton, Dickinson and Company's official filing at the SEC (second-quarter fiscal 2026 Form 10-Q). Amounts are in USD millions and use total assets as the denominator.
- Interest-bearing debt / assets: 34.00%, using $2,573 million of current debt obligations plus $14,706 million of long-term debt.
- Cash plus short-term investments / assets: 1.61%, using $813 million of cash and equivalents plus $3 million of short-term investments.
- Receivables plus cash / assets: 5.94%, using $2,205 million of net trade receivables plus cash.
- Disclosed interest income / revenue: 0.14% for the six-month period. No fixed purification percentage is prescribed here.
All three examined asset-based financial calculations fail on debt. Market-cap denominator methods are not calculated because ZakatInvest does not store a licensed, reproducible historical market-cap series. This is a calculation against named methods, not an official index-membership claim.
Becton Dickinson's business activity
BD makes medical devices, diagnostics, medication-management systems, specimen-collection products, laboratory instruments and interventional products. Medical technology and healthcare-equipment manufacturing is generally permissible at the activity level. The filing does not provide a universal prohibited-revenue numerator by product, customer use or certification, so the quantitative business-activity field remains incomplete rather than inventing a percentage.
Qualitative considerations
- Healthcare portfolio: BD Medical, BD Life Sciences and BD Interventional serve hospitals, laboratories, pharmaceutical partners and other customers; downstream use warrants individual ethical review.
- Legal and product-liability exposure: the filing reports approximately $1.7 billion of accruals for product-liability and certain legal matters at March 31, 2026. This is business and ethical diligence, not an automatic prohibited-activity conclusion.
- Corporate perimeter: the February 2026 Waters/SpinCo separation and discontinued operations can change the reported business mix and financial base.
- Interest income: disclosed interest income is small relative to revenue, but the filing does not prescribe a scholar-approved purification percentage.
Purification and the verdict
Follow the qualified scholar or methodology you use for any purification treatment rather than applying an invented fixed rate. The current financial screen is a fail because debt is 34.00% of assets, while the core medical-technology activity is generally permissible.
BDX is HALAL in ZakatInvest's qualitative classification, but FAIL on the current examined asset-based financial screens. Revisit this record when BD files new statements, changes its debt or corporate perimeter, or materially updates product and legal disclosures.
Use the quantitative screen alongside your school's principles and consult a qualified scholar before investing.
Find halal alternatives →